1-9 of 9
Javier Bolaños-Meade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Allogeneic Blood or Marrow Transplantation for Peripheral T-Cell Lymphoma.

Jennifer A. Kanakry, Yvette L. Kasamon, Christopher D. Gocke, Hua-Ling Tsai, Janice M. Davis-Sproul, Nilanjan Ghosh, Heather J. Symons, MD, MHS, Javier Bolaños-Meade, Douglas E. Gladstone, Lode J. Swinnen, Leo Luznik, Ephraim J. Fuchs, Richard J. Jones, Richard F. Ambinder
Journal: Blood
Blood (2012) 120 (21): 3084.
https://doi.org/10.1182/blood.V120.21.3084.3084
Published: 2012
Journal Articles

Venous Thromboembolism Prevention Practices Among Health Care Providers Caring for Patients Hospitalized for Hematopoietic Stem Cell Transplantation: A International Web-Based Survey

Amer M. Zeidan, MD, Jessica Wellman, PharmD, Patrick Forde, MD, Javier Bolaños-Meade, Michael B. Streiff, MD
Journal: Blood
Blood (2012) 120 (21): 2062.
https://doi.org/10.1182/blood.V120.21.2062.2062
Published: 2012
Journal Articles

Nonmyeloablative Allogeneic (Allo) BMT for B-Cell Lymphoma with Posttransplant Rituximab: Donor Selection by Prioritizing FCGR3A -158 Polymorphism Over HLA Matching.

Yvette L. Kasamon, Richard J. Jones, Christopher D. Gocke, Javier Bolaños-Meade, Lode J. Swinnen, Amanda Blackford, Douglas E. Gladstone, Ephraim J. Fuchs, Richard F. Ambinder
Journal: Blood
Blood (2012) 120 (21): 3107.
https://doi.org/10.1182/blood.V120.21.3107.3107
Published: 2012
Journal Articles

Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy)

Yvette L. Kasamon, Leo Luznik, M. Sue Leffell, Hua-ling Tsai, Heather J. Symons, Javier Bolaños-Meade, Gary Rosner, Lawrence E. Morris, Pamela A. Crilley, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood
Blood (2011) 118 (21): 840.
https://doi.org/10.1182/blood.V118.21.840.840
Published: 2011
Journal Articles

Phase I/II Study of Marrow Infiltrating Lymphocytes (MILs) Generates Measurable Myeloma-Specific Immunity in the Autologous Stem Cell Transplant (SCT) Setting

Kimberly Noonan, MPH, Carol A. Huff, MD, Janice M Davis Sproul, MAS, MT(ASCP), SBB, Mario Victor M Lemas, PhD, Lakshmi Rudraraju, MS, Leo Luznik, Jonathan Powell, MD, PhD, Javier Bolaños-Meade, Jeffrey Bitzan, MT, Susan Fiorino, MT(ASCP), William Matsui, MD, Richard J. Jones, MD, Ivan M. Borrello, MD
Journal: Blood
Blood (2011) 118 (21): 997.
https://doi.org/10.1182/blood.V118.21.997.997
Published: 2011
Journal Articles

High-Dose Cyclophosphamide (Cy), Rituximab, and a Cancer Vaccine for Relapsed Classical Hodgkin's Lymphoma (cHL)

Yvette L. Kasamon, Richard J. Jones, Hyam I. Levitsky, Ivan M. Borrello, M. Victor Lemas, Michael J. Borowitz, Javier Bolaños-Meade, Lode J. Swinnen, Richard F. Ambinder
Journal: Blood
Blood (2010) 116 (21): 3954.
https://doi.org/10.1182/blood.V116.21.3954.3954
Published: 2010
Journal Articles

Greater HLA Disparity Is Associated with Reduced Risk of Relapse and Improved Event-Free Survival after Nonmyeloablative, HLA-Haploidentical BMT with Post-Transplantation High-Dose Cyclophosphamide

Yvette L. Kasamon, Mary S. Leffell, Jeanne Kowalski, Hua-Ling Tsai, Nancy Rossiter, Lawrence E. Morris, Pamela A. Crilley, Leo Luznik, Javier Bolaños-Meade, Paul V. O’Donnell, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood
Blood (2008) 112 (11): 150.
https://doi.org/10.1182/blood.V112.11.150.150
Published: 2008
Journal Articles

Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts).

Ashrof Z. Badros, MD, Javier Bolaños-Meade, MD, Aaron Rapoport, MD, Bashi Ratterree, RN, Sabrina Natt, RN, Kathy Ruehle, RN, Kathy McNamara, RN, Edmund Cox, Sandy Westphal, Robert Fenton, MD, PhD, Barry Meisenberg, MD.
Journal: Blood
Blood (2004) 104 (11): 5007.
https://doi.org/10.1182/blood.V104.11.5007.5007
Published: 2004
Journal Articles

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Ashrof Z. Badros, MD, Olga Goloubeva, PhD, Bashi Ratterree, RN, Sabrina Natt, RN, Aaron Rapoport, MD, Javier Bolaños-Meade, MD, Ben Zhang, PhD, Jerry Zeldis, MD, PhD, Stanley Frankel, MD, Barry Meisenberg, MD, James Zwiebel, MD, J. Flaws, PhD, D. Tomic, PhD, Robert Fenton, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2400.
https://doi.org/10.1182/blood.V104.11.2400.2400
Published: 2004